Propofol infusion syndrome - A case report;Das propofol-infusions-syndrom - Ein fallbericht

Anasthesiologie und Intensivmedizin

Volumn 45, Issue 10, 2004, Pages 580-584

  Hein, Swantje ^a   Benken, I ^a   Quintel, M ^a   Kettler, D ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Children; Congestive Heart Failure; Propofol; Rhabdomyolysis; Sedation

Indexed keywords

ADENOSINE; AMIODARONE; CATECHOLAMINE; CEFOTAXIME; LIDOCAINE; METHYLPREDNISOLONE; PIRITRAMIDE; PROPOFOL; ROCURONIUM; STEROID;

ACUTE KIDNEY FAILURE; ARTICLE; ASTROCYTOMA; CASE REPORT; CHILD; HEART DISEASE; HUMAN; MALE; METABOLIC ACIDOSIS; PATHOGENESIS; PROPOFOL INFUSION SYNDROME; RHABDOMYOLYSIS; RISK FACTOR; SEDATION; SYNDROME;

EID: 6344247487     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141.
2. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998;8(6):491-499.
3. Cray SH. Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998;26(12):2087-92.
4. Vasile B. Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29(9):1417-25. Epub 2003 Aug 06.
5. Marinella MA. Lactic acidosis associated with propofol. Chest 1996;109(1):292.
6. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem 2000;46(4):577-81.
7. Wolf A, Weir R Segar R Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; Feb 24;357 (9256):606-7.
8. Ernest D. French C. Propofol infusion syndrome-report of an adult fatality. Anaesth Intensive Care 2003;31(3):316-9.
9. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998;50 (1):301-3. Review
10. Parke TJ, Stevens JE, Rice AS, Greenaway CL, Bray RJ, Smith PJ, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992 Sep 12;305(6854): 613-6.
11. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al.: Groupe de Reflexion et d'Etude des Neuromyopathies en Reanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002 Dec 11;288(22):2859-67.
12. Mitch WE, Price SR. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Ren Nutr 2003;13(2):149-52.
13. Myburgh JA, Upton RN, Grant C, Martinez A. The effect of infusions of adrenaline, noradrenaline and dopamine on cerebral autoregulation under propofol anaesthesia in an ovine model. Intensive Care Med 2003;29(5):817-24. Epub 2003 Feb 21
14. Myburgh JA, Upton RN, Grant C, Martinez A. Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model. Intensive Care Med 2001;27(1):276-82.
15. Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001 Aug 14;104(7):756-61.
16. Sanchez-Soria MM, Morales-Garcia C, Cuena-Boy R, Castellano-Hernandez M. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 2001; 29:317-22.
17. Ewart MC, Yau KW, Morgan M. 2% propofol for sedation in the intensive care unit. A feasibility study. Anaesthesia 1992;47(2): 146-8.
18. Doenicke AW, Roizen ME Rau J, O'Connor M, Kugler J, Klotz U, Babl J. Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg 1997;85(6):1399-403.
19. Piper SN, Kumle B, Maleck WH, Suttner SW, Fent MT, Boldt J. Effects of postoperative sedation with propofol and midazolam on pancreatic function assessed by pancreatitis-associated protein. Anaesthesia. 2001;56(9):836-40.
20. Bucheler R, Schwab M, Morike K, Kalchthaler B, Mohr H, Schroder H, et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 2002 Jun 1;324(7349): 1311-2.
21. Aitkenhead AR, Pepperman ML, Willatts SM, Coates PD, Park GR, Bodenham AR, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989 Sep 23;2(8665): 704-9.
22. Martin PH, Murthy BV, Petros AJ. Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care. Br J Anaesth 1997;79 (3):276-9.
23. Newman LH, McDonald JC, Wallace PG, Ledingham IM. Propofol infusion for sedation in intensive care. Anaesthesia 1987;42(9):929-37.
24. Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002;110(6):1177-81.
25. Felmet K, Nguyen T, Clark RS, Orr D, Carcillo J. Author's reply 1002-Pediatrics 2003;112(4):1002-3; 3.
26. Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001 Jan 13;357(9250):117-8.
27. Strauss JM, Giest J. Totale intravenöse Anästhesie. Anaesthesist 2003;52(9):763-77.